DLH Reports Fiscal 2022 Third Quarter Results

Revenue of $66.4 Million, up 8% Year-over-Year; Earnings $0.34…

GRSi Awarded $48M Advanced Technology Contract by NIH’s Office of Innovation and Information Technology (OIIT)

GRSi, a provider of state-of-the-art innovations and solutions…

DLH Awarded NIH Cancer Epidemiology and Genetics Contract

Atlanta, Georgia – July 11, 2022 - DLH Holdings Corp. (NASDAQ:…

DLH-Supported Project Named 2022 FedHealthIT Innovation Award Winner

DLH-Supported Project Team Successfully Connects Supply-Chain…

DLH Wins Renewal of National Institute of Health Contract for Statistical Support

DLH announced it has been awarded a contract to provide statistical, mathematical, and computational support for NIEHS research.

DLH Awarded DHA OMNIBUS IV Military Medical Research and Development Contract

DLH announced that it has been awarded an Indefinite Delivery/Indefinite Quantity (ID/IQ) multiple award contract to provide health-related research and development and support services to the Department of Defense (“DoD”).

DLH Reports Fiscal 2022 Second Quarter Results

Revenue $108.7 Million, Reflecting Short-term FEMA Awards;…

DLH to Announce Second Quarter FY22 Financial Results

DLH will release financial results for its fiscal second quarter ended March 31, 2022 on May 4, 2022 after the market closes.